CellBxHealth’s new CEO pivots strategy amid financial turnaround efforts
CellBxHealth’s CEO Peter Collins has explained plans to restructure the company following its rebrand from ANGLE in October. The company…
19 Dec 2025
Curasight doses first patient in Phase I brain cancer trial of uTREAT
Denmark-based Curasight has dosed the first patient in the Phase I clinical trial of its uTREAT diagnostic platform, targeting high-grade gliomas. The trial marks the company’s initial clinical study investigating…
19 Dec 2025
Abbott secures FDA and CE Mark approvals for Amplatzer delivery system
Abbott has secured the US Food and Drug Administration (FDA) and CE Mark approvals for its Amplatzer Piccolo delivery system, designed for premature infants diagnosed with patent ductus arteriosus (PDA).…
18 Dec 2025
EDX Medical plans UK bowel cancer testing service launch
EDX Medical is launching a bowel cancer testing service in the UK in the coming weeks that is intended to improve the early-stage detection of the disease. The UK-based diagnostic…
18 Dec 2025
New report highlights challenges hampering hospital connected device security
A new survey by cybersecurity company Asimily has identified that persistent visibility gaps and internal process breakdowns are among the biggest security challenges being faced by hospital chief information security…
18 Dec 2025
MARAbio introduces MAR-Autism Test to detect maternal autoantibodies
MARAbio Systems has commercially introduced a new blood test for identifying maternal autoantibody-related autism. The MAR-Autism Test is designed to detect specific autoantibodies responsible for an autism subtype known as…
18 Dec 2025
FDA clears SleepRes’ Kricket PAP device for obstructive sleep apnoea
The US Food and Drug Administration (FDA) has granted 510(k) clearance to SleepRes’ Kairos positive airway pressure (KPAP)-powered Kricket PAP device for the treatment of obstructive sleep apnoea (OSA). Intended…